Literature DB >> 19804934

A population-based study on the prevalence and determinants of cardiopulmonary resuscitation in the last month of life for Taiwanese cancer decedents, 2001-2006.

Jen-Shi Chen1, Hung-Ming Wang, Shiao-Chi Wu, Tsang-Wu Liu, Yen-Ni Hung, Siew Tzuh Tang.   

Abstract

BACKGROUND: The success rate of cardiopulmonary resuscitation (CPR) for cancer patients following in-hospital cardiac arrest has remained poor over the last 3 decades, but little is known about determinants of undergoing CPR for these patients at the end of life.
OBJECTIVE: To determine the prevalence of CPR for Taiwanese cancer patients in the last month of life and the association between their undergoing CPR and patient demographics, disease characteristics, physician specialty, hospital characteristics, and availability of healthcare resources at the hospital and regional levels.
METHODS: This retrospective cohort study examined administrative data for a cohort of 204,850 cancer decedents in 2001-2006.
RESULTS: Rates of CPR decreased substantially over the study period, from 13.18% to 8.63%, and the adjusted odds ratio of undergoing CPR decreased significantly by a factor of 0.93 for each successive year. Taiwanese cancer patients were predisposed to undergo CPR in their last month of life if they were male, young, and unmarried (except for widowhood); had high comorbidity; had certain cancers (hematological malignancies, head and neck, esophageal, and prostate cancers); had a localized or newly diagnosed (within 1-2 months of death) cancer; had a non-oncologist as their primary physician; and received care at a non-teaching hospital.
CONCLUSION: One-tenth of Taiwanese cancer patients underwent CPR in the last month of life, and the rates of CPR decreased substantially from 2001 to 2006. The propensity for CPR was influenced by patient demographics, disease characteristics, physician specialty, and teaching status of the patient's primary hospital.

Entities:  

Mesh:

Year:  2009        PMID: 19804934     DOI: 10.1016/j.resuscitation.2009.08.015

Source DB:  PubMed          Journal:  Resuscitation        ISSN: 0300-9572            Impact factor:   5.262


  6 in total

1.  Timing of code status documentation and end-of-life outcomes in patients admitted to an oncology ward.

Authors:  Amanda Caissie; Nanor Kevork; Breffni Hannon; Lisa W Le; Camilla Zimmermann
Journal:  Support Care Cancer       Date:  2014-02       Impact factor: 3.603

Review 2.  Do not resuscitate orders and aging: impact of multimorbidity on the decision-making process.

Authors:  L de Decker; C Annweiler; C Launay; B Fantino; O Beauchet
Journal:  J Nutr Health Aging       Date:  2014-03       Impact factor: 4.075

3.  Resource use, costs and quality of end-of-life care: observations in a cohort of elderly Australian cancer decedents.

Authors:  Julia M Langton; Preeyaporn Srasuebkul; Rebecca Reeve; Bonny Parkinson; Yuanyuan Gu; Nicholas A Buckley; Marion Haas; Rosalie Viney; Sallie-Anne Pearson
Journal:  Implement Sci       Date:  2015-02-26       Impact factor: 7.327

4.  Impact of Palliative Care Consultation Service on Terminally Ill Cancer Patients: A 9-Year Observational Cohort Study in Taiwan.

Authors:  Ching-Yi Lu; Wen-Chi Shen; Chen-Yi Kao; Hung-Ming Wang; Shu-Chuan Tang; Tsu-Ling Chin; Chuan-Chuan Chi; Jin-Mei Yang; Chih-Wen Chang; Ying-Fen Lai; Ya-Chi Yeh; Yu-Shin Hung; Wen-Chi Chou
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

5.  Care of cancer patients at the end of life in a German university hospital: A retrospective observational study from 2014.

Authors:  Burkhard Dasch; Helen Kalies; Berend Feddersen; Caecilie Ruderer; Wolfgang Hiddemann; Claudia Bausewein
Journal:  PLoS One       Date:  2017-04-06       Impact factor: 3.240

Review 6.  The palliative care needs and experiences of people with advanced head and neck cancer: A scoping review.

Authors:  Catriona R Mayland; Qiaoling Marilyn Ho; Hannah C Doughty; Simon N Rogers; Prithvi Peddinti; Praytush Chada; Stephen Mason; Matthew Cooper; Paola Dey
Journal:  Palliat Med       Date:  2020-10-21       Impact factor: 4.762

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.